secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2023-11-17T23:59:59+00:00
Accession:  0001493152-23-041914
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions receives Nasdaq delisting notices for low equity and bid price
--------------------------------------------------------------------------------

- Received Nasdaq deficiency letter for stockholders' equity of $1.24M, below $2.5M minimum; must submit plan by Jan 2, 2024.
- Also received bid price deficiency; closing bid below $1.00 for 30 consecutive days; cure period until May 14, 2024.
- At special meeting, stockholders approved issuance of up to 15,921,888 shares upon exercise of warrants from Oct 2023 offering.
- Ratified UHY LLP as independent auditor for fiscal year ending June 30, 2024.
- Company believes it now meets equity requirement but no assurance of acceptance of compliance plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315223041914/0001493152-23-041914-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315223041914/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-041914

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer